GlassScriptPhysician profile
Zsolt Kulcsar
NPI 1326209065
$9,675.50
in general payments reported to CMS, 2019-2025
9 companies · $7,204 in 2025
The $7,204 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $129 · 2021: $282 · 2022: $44.62 · 2024: $1,500 · 2025: $7,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,175 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,150 · Travel and Lodging: $314 · Food and Beverage: $65.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,175.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,150.00 |
| Travel and Lodging | $313.88 |
| Food and Beverage | $65.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,969.79 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $342.81 | 2019 | |
| Medtronic, INC. | $232.74 | 2021 | |
| Pfizer INC. | $31.02 | 2019 | |
| Celgene Corporation | $30.20 | 2019 | |
| Ucb, INC. | $23.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.54 | 2021 | |
| Amgen INC. | $15.57 | 2019 | |
| Genentech USA, INC. | $10.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zsolt Kulcsar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.